We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Test Measures Three Levels of Estradiol

By HospiMedica staff writers
Posted on 12 Oct 2004
A new improved test for estradiol is a chemiluminescent microparticle immunoassay (CMIA) that provides an initial result in 29 minutes.

The test, designed for use on the Architect systems of Abbott Laboratories (Abbott Park, IL, USA), measures low, medium, and high concentration levels of estradiol. More...
The company notes that estradiol testing can be useful for a variety of conditions, including early or delayed puberty, and can also play an important role in the treatment of infertility. The Architect i2000 and i2000SR systems can process up to 200 immunoassay tests an hour without compromising test throughput or turnaround time.

"The Architect estradiol test was designed to be sensitive and specific, providing precise results across the entire assay range,” noted William Brown, Ph.D., vice president, diagnostic assays and systems development, Abbott Laboratories. "In addition, Architect estradiol has excellent correlation to the ‘gold standard' gas chromatography mass spectrometry (GC-MS) testing. This correlation supports the excellent functional sensitivity and accuracy of the assay.”

Estradiol levels vary, depending on the condition being treated. Levels are usually low in children and men, but in women the levels rise and fall during the normal menstrual cycle. Thus, a diagnostic test has to be able to provide precise results across a wide measurement range.


Related Links:
Abbott Labs

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.